demonstrated that circ_0011292 promoted PTX resistance in NSCLC via modulating the miR-379-5p/TRIM65 axis, indicating that knocking down circ_0011292 might be a feasible therapeutic option for PTX resistance in NSCLC (95). Here, TRIM65 is linked to non-small cell lung carcinoma.